Clinical trials
Psoriasis clinical trials
A skin condition that causes a rash with itchy, scaly patches. We’re tracking 162 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT04950218Recruiting
Study risks of heart problems in people with psoriasis
This study asks adults with psoriasis about factors that may be linked to heart problems. It aims to better understand who is at higher risk, which could help guide future prevention and care.
Hellerup, CopenhagneAges 18 years+ - NCT03392337Recruiting
Narrowband UVB light therapy for moderate to severe plaque psoriasis
This study tests whether narrowband ultraviolet B (UVB) light given three times a week for 12 weeks improves moderate-to-severe plaque psoriasis. It is an “open-label” pilot, meaning everyone gets the UVB treatment and researchers track how your skin responds.
East Windsor, New JerseyAges 18 years+ - NCT03827876RecruitingPhase 4
Enstilar added to Enbrel or Humira for plaque psoriasis
This trial tests whether adding Enstilar (a skin spray/foam medication) on top of your usual injection—Enbrel or Humira—works better for plaque psoriasis. You might be a candidate if your psoriasis affects a moderate amount of skin and you’ve been on Enbrel or Humira long enough.
East Windsor, New JerseyAges 18 years+ - NCT04347473RecruitingPhase 4
ILUMYA plus halobetasol ointment for plaque psoriasis
This trial studies whether ILUMYA (an injection) working together with halobetasol ointment helps control moderate-to-severe plaque psoriasis. It is meant for adults whose psoriasis is significant enough that they may need light therapy (phototherapy) and/or pills/injections (systemic therapy).
East Windsor, New JerseyAges 18 years+ - NCT04372277RecruitingPhase 4
Adding Enstilar to Taltz for plaque psoriasis
This trial studies whether using Enstilar (a medicated skin spray/foam) together with Taltz works better than staying on Taltz alone for chronic plaque psoriasis. It focuses on adults with a specific amount of body skin affected by psoriasis who have already been on Taltz for at least 24 weeks.
East Windsor, New JerseyAges 18 years+ - NCT07780929Recruiting
Study of XJH05 ointment for mild-to-moderate plaque psoriasis
This trial tests a new ointment (XJH05) for people with mild-to-moderate plaque psoriasis. It aims to see if this treatment helps reduce symptoms and is safe for topical use.
Xi'an, ShaanxiAges 18–65 - NCT07725822RecruitingPhase 4
Cream for psoriasis affecting skin and nails
This study tests a new prescription cream called roflumilast to see if it helps with both skin plaques and nail psoriasis. If you join, you'll apply the cream to affected areas and be monitored to see how well it works and if it's safe.
Dallas, TexasAges Any age - NCT07545902Recruiting
Urea-based creams for plaque and palm-sole psoriasis
This study tests two medicated creams containing urea (a natural moisturizing ingredient) to treat psoriasis on the skin and on the palms and soles of the feet. The creams may help reduce flaking, scaling, and irritation in people with mild psoriasis.
Chieti, ItaliaAges 18–65 - NCT07426120RecruitingPhase 3
Coumarin cream for psoriasis: a research study
This study tests a cream made from a natural plant compound (coumarin) to see if it can help treat plaque psoriasis. If you have mild-to-moderate psoriasis and haven't used certain other treatments recently, this trial may be an option for you.
New York, New YorkAges 18–70 - NCT07370766Recruiting
Tildrakizumab for moderate-to-severe psoriasis in Canada
This study looks at how well tildrakizumab works for people with moderate-to-severe plaque psoriasis who are starting this treatment through a support program in Canada. Researchers want to see how it affects your symptoms and daily life.
Burlington, OntarioAges 18 years+ - NCT07234591Recruiting
Study of an oral medication for moderate to severe plaque psoriasis
This study tests an experimental oral medication (a TYK2 inhibitor) for people with moderate to severe plaque psoriasis. It aims to see if the drug is safe and effective at reducing psoriasis symptoms.
ShanghaiAges 18–70 - NCT07149792RecruitingPhase 4
Personalized treatment study for psoriasis and joint health
This study tests whether a personalized treatment plan can help people with psoriasis and psoriatic arthritis, and also looks at how these conditions affect the heart. The goal is to find better ways to treat you and protect your heart health.
Taichung, TaiwanAges 18–75 - NCT06987292Recruiting
Studying IL-17 inhibitors for hidden tendon inflammation in psoriasis
This study tests whether IL-17 inhibitor medications can reduce inflammation in tendons and ligaments that is not visible on the skin but can be detected with a special ultrasound. It may be an option for people with moderate to severe psoriasis who have not had enough relief from creams or light therapy.
Nanjing, JiangsuAges 18 years+ - NCT04119102RecruitingPhase 4
Duobrii added to biologic treatment for plaque psoriasis
This trial tests whether adding Duobrii (a prescription psoriasis lotion) on top of your current biologic treatment helps improve plaque psoriasis. It includes adults whose psoriasis is in a moderate range and who have already been on a biologic for at least 24 weeks.
East Windsor, New JerseyAges 18 years+ - NCT04537689RecruitingPhase 4
Test ixekizumab and stopping it in plaque psoriasis
This study looks at how well ixekizumab (an injection medication) works for moderate-to-severe plaque psoriasis, and what happens when the treatment is withdrawn. It may help you learn whether stopping the medicine is safe and how skin disease outcomes change over time.
Outram ParkAges 22–90 - NCT04465838Recruiting
Real-world study of psoriasis care in clinic
This study looks at people with psoriasis who are diagnosed by a dermatologist in regular clinic care. It mainly collects real-world information and may help improve how psoriasis is understood and treated in everyday practice.
Hangzhou, ZhejiangAges Any age - NCT05503875Recruiting
Study uses psoriasis “immune patterns” to guide treatment
This study looks at immune system differences in people with moderate-to-severe psoriasis. It aims to help guide more precise (targeted) treatment choices and may improve how well treatment works for you.
Hangzhou, ZhejiangAges 18–75 - NCT07858591Recruiting
Eye scans for people with psoriatic arthritis
This study uses eye scans to look at tiny blood vessels in the back of the eye and a small area called the fovea, to see if they are different in people with psoriatic arthritis compared to people without it. This might help doctors understand more about psoriatic arthritis and its effects on the body.
Bursa, YıldırımAges 18–75 - NCT06382987Recruiting
Comparing deucravacitinib vs apremilast for plaque psoriasis
This study compares two oral medications, deucravacitinib and apremilast, for adults with plaque psoriasis in Japan. It looks at how well each drug works in real-world use.
Minato-ku, TokyoAges 18 years+ - NCT04359394Recruiting
Rare severe pustular psoriasis family DNA study network
This study builds a large international registry of people with rare, severe pustular psoriasis to help doctors understand the genetics of the condition. You may be asked for information and, if you have eligible family members, DNA testing to learn how the disease runs in families.
MünchenAges 6 months+ - NCT07844772Recruiting
Psoriasis treatment and nerve pain study
This study looks at how different psoriasis treatments affect nerve-related pain and sensitivity. It compares patients on biologic injections, standard pills, or creams to see if treatment type matters for pain and skin symptoms.
Istanbul, IstanbulAges 18 years+ - NCT05122039Recruiting
Follow-up study for people with psoriasis
This study follows people with psoriasis over time to better understand the condition and how it changes. You may be able to join if your psoriasis started more than 3 years ago and you can agree to take part.
Leuven, Vlaams-BrabantAges 12–70 - NCT05744466Recruiting
Compare two psoriasis medicines using real-world patient data
This study looks at how well two common plaque psoriasis medicines—deucravacitinib and apremilast—work in everyday care. It may help researchers understand which option performs better in real patients outside of a traditional drug trial.
Waltham, MassachusettsAges 18 years+ - NCT07746583Recruiting
Switching from ustekinumab to guselkumab for psoriasis
This study is testing a medicine called guselkumab (Tremfya) for people with psoriasis who are already taking another biologic medicine, ustekinumab, but need to switch. The goal is to see how well guselkumab works in real-world use.
BudapestAges 18 years+
Hear when a new Psoriasis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Psoriasis trials by city
Studies with a site in or near these metro areas.
Psoriasis trials by state
Studies with a site anywhere in these states.
Common questions
- Are there clinical trials for psoriasis?
- Yes. Clin2 currently lists 162 recruiting psoriasis studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a psoriasis trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a psoriasis trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.